2 results
Approved WMOPending
The primary objective is to characterize the change in the Pharmacodynamic (PD) biomarker, fecal calprotectin, during treatment with anrukinzumab.The secondary objectives include:* Characterization of the PK profile and total IL-13 of three multiple…
Approved WMOPending
The objective of this study is to find out whether women with OSA treated with Autoset For Her experience a greater improvement in sleep-related problems compared to the Autoset standard.We also want to investigate whether the pressure is higher…